Analysis: Arm IPO filing reveals depth of Chinese risk
By Peter Clarke, eeNews Europe
August 22, 2023
The filing for an IPO in intellectual property licensor Arm has revealed details of problematic relations in China and risks to its continued business there.
A key factor is that after Arm stages its IPO it will still be SoftBank Group that retains the largest stake in Arm Technology (China) Co. Ltd. which is the gateway to Arm’s China revenues. And SoftBank Group and Arm together only hold a 48 percent interest in the Arm China.
Several years ago, Arm – presumably under pressure from the government of the People’s Republic of China – opted to cease having a wholly- or majority-owned subsidiary to manage licensing and royalty collection. In a series of manoeuvres Arm was moved into a minority ownership position in Arm Technology (China) Co. Ltd.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
Related News
- Arm Announces Public Filing of Registration Statement for Proposed Initial Public Offering
- IAR unveils Functional Safety version of IAR Embedded Workbench for Arm equipped with certified static analysis capabilities
- Arm IPO Likely to Lag Early Expectations, Observers Say
- Arm Announces Launch of IPO Roadshow
- Arm prices IPO
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design